Two Sigma Securities, LLC Bio N Tech Se Call Options Transaction History

Two Sigma Securities, LLC

  • $5.78 Billion
  • Q3 2024

Call Options

11 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$78.36 - $124.66 $1.27 Million - $2.02 Million
16,200 New
16,200 $1.92 Million
Q1 2024

May 15, 2024
SELL
$88.96 - $112.35 $400,320 - $505,575
-4,500 Reduced 30.41%
10,300 $950,000
Q4 2023

Feb 14, 2024
BUY
$90.91 - $112.75 $854,554 - $1.06 Million
9,400 Added 174.07%
14,800 $1.56 Million
Q3 2023

Nov 14, 2023
SELL
$98.5 - $125.08 $265,950 - $337,716
-2,700 Reduced 33.33%
5,400 $586,000
Q2 2023

Aug 14, 2023
SELL
$102.58 - $129.66 $1.24 Million - $1.57 Million
-12,100 Reduced 59.9%
8,100 $874,000
Q1 2023

May 15, 2023
BUY
$122.57 - $153.67 $2.48 Million - $3.1 Million
20,200 New
20,200 $2.52 Million
Q2 2022

Aug 15, 2022
SELL
$123.25 - $186.24 $1.77 Million - $2.68 Million
-14,400 Reduced 58.06%
10,400 $1.55 Million
Q1 2022

May 16, 2022
BUY
$126.25 - $231.85 $2.94 Million - $5.4 Million
23,300 Added 1553.33%
24,800 $4.23 Million
Q4 2021

Feb 14, 2022
SELL
$216.64 - $362.52 $2.34 Million - $3.92 Million
-10,800 Reduced 87.8%
1,500 $387,000
Q3 2021

Nov 15, 2021
BUY
$205.93 - $447.23 $1.94 Million - $4.2 Million
9,400 Added 324.14%
12,300 $3.36 Million
Q2 2021

Aug 16, 2021
BUY
$113.32 - $241.49 $328,628 - $700,321
2,900 New
2,900 $649,000

Others Institutions Holding BNTX

# of Institutions
356
Shares Held
38.3M
Call Options Held
2.45M
Put Options Held
2.29M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $27.5B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email